Roche, Spark extend $4.3 bln takeover again, this time to Sept. 3
July 31, 2019 at 01:11 AM EDT
Roche and Spark Therapeutics announced another extension of the Swiss drugmaker's $4.3 billion takeover offer for the U.S. gene therapy specialist as regulatory reviews in the United States and Britain continue.
